您的购物车当前为空
别名 磷酸三(1,3-二氯异丙基)酯, Tris(1,3-dichloroisopropyl)phosphate, Fyrol FR 2
TDCPP (Fyrol FR 2) 是氯化三烷基有机磷酸酯阻燃剂 (OPFR) 化合物组的成员,是在环境中检测到的最多的有机磷阻燃剂之一,主要用作商业产品中的添加剂。


为众多的药物研发团队赋能,
让新药发现更简单!
TDCPP (Fyrol FR 2) 是氯化三烷基有机磷酸酯阻燃剂 (OPFR) 化合物组的成员,是在环境中检测到的最多的有机磷阻燃剂之一,主要用作商业产品中的添加剂。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | ¥ 166 | In stock | |
| 25 mg | ¥ 248 | In stock | |
| 50 mg | ¥ 349 | In stock | |
| 100 mg | ¥ 498 | In stock | |
| 500 mg | ¥ 1,190 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 558 | In stock |
| 产品描述 | TDCPP (Fyrol FR 2) is classified under the chlorinated trialkyl organophosphate flame retardant (OPFR) group of compounds primarily utilized as additives in commercial products. |
| 体外活性 | 在TDCPP暴露后,细胞活性呈剂量依赖性下降,LC50为202 μg/mL。在HCECs中,暴露于≥2 μg/mL TDCPP后,观察到浓度依赖性的凋亡迹象。内质网应激的诱导通过其生物标志基因(ATF-4, CHOP, BiP, XBP1)的上调得到证实。此外,在暴露于2或20 μg/mL TDCPP后,观察到Bcl-2/Bax表达的变化、线粒体膜电位的丧失、细胞ATP含量的降低、以及caspase-3和-9活性的增加。这些发现暗示内质网应激在TDCPP引起的HCEC凋亡中的参与,可能是通过线粒体凋亡途径介导的。TDCPP暴露对人类角膜造成了毒性。 |
| 细胞实验 | Human corneal epithelial cells (HCECs) were cultured in DMEM supplemented with 10% FBS, 10 ng/mL EGF, and 1% penicillin-streptomycin solution in an incubator with 5% CO2 at 37℃.?After reaching confluence, HCECs were replanted into 6/24/ 96-well plates or petri dishes with different initial densities and cultured for 24 h to reach ~70% confluence.?Then, TDCPP dissolved in n-hexane was solvent-exchanged to DMSO and serially diluted by DMEM to achieve concentrations from 0.034 to 340 μg/mL.?For cell exposure, the culture medium was aspirated and treated with TDCPP solutions (DMSO <0.1%) for 24 h with 0.1% DMSO solution as vehicle control[1]. |
| 别名 | 磷酸三(1,3-二氯异丙基)酯, Tris(1,3-dichloroisopropyl)phosphate, Fyrol FR 2 |
| 分子量 | 430.90 |
| 分子式 | C9H15Cl6O4P |
| CAS No. | 13674-87-8 |
| Smiles | P(OC(CCl)CCl)(OC(CCl)CCl)(OC(CCl)CCl)=O |
| 密度 | 1.512 |
| 颜色 | Transparent |
| 物理性状 | Oil |
| 存储 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 60.00 mg/mL (139.24 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.64 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容